Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 12;12(9):751.
doi: 10.3390/bios12090751.

EEG Evaluation in a Neuropsychological Intervention Program Based on Virtual Reality in Adults with Parkinson's Disease

Affiliations

EEG Evaluation in a Neuropsychological Intervention Program Based on Virtual Reality in Adults with Parkinson's Disease

Daniela Muñoz et al. Biosensors (Basel). .

Abstract

Nowadays, several strategies for treating neuropsychologic function loss in Parkinson’s disease (PD) have been proposed, such as physical activity performance and developing games to exercise the mind. However, few studies illustrate the incidence of these therapies in neuronal activity. This work aims to study the feasibility of a virtual reality-based program oriented to the cognitive functions’ rehabilitation of PD patients. For this, the study was divided into intervention with the program, acquisition of signals, data processing, and results analysis. The alpha and beta bands’ power behavior was determined by evaluating the electroencephalography (EEG) signals obtained during the execution of control tests and games of the “Hand Physics Lab” Software, from which five games related to attention, planning, and sequencing, concentration, and coordination were taken. Results showed the characteristic performance of the cerebral bands during resting states and activity states. In addition, it was determined that the beta band increased its activity in all the cerebral lobes in all the tested games (p-value < 0.05). On the contrary, just one game exhibited an adequate performance of the alpha band activity of the temporal and frontal lobes (p-value < 0.02). Furthermore, the visual attention and the capacity to process and interpret the information given by the surroundings was favored during the execution of trials (p-value < 0.05); thus, the efficacy of the virtual reality program to recover cognitive functions was verified. The study highlights implementing new technologies to rehabilitate people with neurodegenerative diseases.

Keywords: Parkinson’s disease; cognitive functions; electroencephalography; virtual reality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The general methodology was followed for the viability study of the VR intervention program in people diagnosed with PD.
Figure 2
Figure 2
Assembly was carried out during the intervention with the VR system performed in the rehabilitation center in Chile.
Figure 3
Figure 3
Distribution of the alpha and beta bands’ relative power by cerebral lobes of the control tests: (A) Opened eyes (OE). (B) Closed eyes (CE).
Figure 4
Figure 4
Distribution of the alpha and beta bands’ relative power by cerebral lobes of the software Hand Physics Lab games. (A) Finger Painting (FP). (B) Sorting Cubes (SC). (C) More Switches (MS). (D) Zero Gravity Switches (ZG). (E) and Punch the Dummy (PD).
Figure 5
Figure 5
Results of the satisfaction survey displayed through satisfaction percentages according to each question performed, where 100 corresponds to “very satisfied” and 0 corresponds to “very unsatisfied”.
Figure 6
Figure 6
Categories considered by the users as the most important ones regarding the questions completed in the satisfaction survey.

References

    1. Tysnes O. Epidemiology of Parkinson’s disease. J. Neural Transm. 2017;124:901–905. doi: 10.1007/s00702-017-1686-y. - DOI - PubMed
    1. Ball N. Parkinson’s Disease and the Environment. J. Neurochem. 2016;139:318–324. doi: 10.3389/fneur.2019.00218. - DOI - PubMed
    1. Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J. Neuro-Chem. 2016;139:318–324. doi: 10.1111/jnc.13691. - DOI - PubMed
    1. Hirsch L. The Incidence of Parkinson’s Disease: A Systematic Review and Meta- Analysis. Neuroepidemiology. 2016;46:292–300. doi: 10.1159/000445751. - DOI - PubMed
    1. Navartnam P. Natural history and patterns of treatment change in Parkinson’s disease: A retrospective chart review. Clin. Park. Relat. Disord. 2022;6:100–125. doi: 10.1016/j.prdoa.2021.100125. - DOI - PMC - PubMed